Steriscience Specialties Private Limited - Due diligence report

A 360° intelligence report on Steriscience: trust score, financial health, credit view, compliance, directors, growth and distress signals -…

2020-08-29 Thane, Maharashtra Active Unlisted
Share
SS Steriscience Specialties Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Steriscience — 360° Intelligence Report

Generated from MCA filings & public records
70/100
Trust Score
Moderate

Steriscience is assessed as Moderate with a Trust Score of 70/100. Steriscience is an active private limited indian non-government company incorporated in 2020, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Steriscience Specialties Private Limited snapshot & full profile →

Financial Health › Neutral
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
70/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
80/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
45/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
20/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
85/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
90/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
65/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 3 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 20/100 Caution Indicated
  • Liabilities ≈ 38% EBITDA - stretched.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Elevated gearing (D/E 1.42).

Charges position: 4 open (308.00 cr) · 3 satisfied (225.00 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Hdfc Bank Limited2 48.0 cr
Others4 48.0 cr
Yes Bank Limited1 48.0 cr
Compliance Score: 80/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
  • Delayed payments to MSME suppliers disclosed (139 disclosure(s)).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 85/100
NameDIN / PANDesignationAppointedTenureDIN status
CHANDRAPPA SEETHARAMAIAH 01234567 Director 01/04/2018 6 yrs Approved
Chhitiz Saraogi 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • 2 director exit(s) in the last 3 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Tenshi Pharmaceuticals Private Limited
Subsidiaries
1
Group entities
2
Capital events
7 allotment(s) · 3 transfer(s)

Promoters hold a majority stake - exact percentages are part of the full report.

Group entityRelationship% held
Tenshi Pharmaceuticals Private Limited Holding Company 74.00%
Steribrooks Penems Private Limited Subsidiary Company 74.00%
Brooks Steriscience Limited Joint Ventures 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 90 · Distress 65
Growth signals & trust indicators
Revenue acceleration: +2.1x over 2 year(s).
Latest year revenue grew 24%.
Asset base grew 0.86 - capacity expansion.
EPFO headcount growing - hiring signal.
Operating for 5 years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Losses deepening year-on-year.
Outside liabilities up 61% in a year.
4 open charge(s) registered - assets are encumbered.
MSME payment delays disclosed - latest outstanding 1.89 cr.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence72/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment42/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 4 open charge(s) of 308.00 cr already registered.
  • Compliance record supports lending.
Investor view69/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 4 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
17 Jun 2025
Charge satisfied
Others
25 Apr 2025
Charge satisfied
Others
24 Apr 2025
Charge satisfied
Yes Bank Limited
20 Sep 2024
Last AGM held
Annual general meeting
19 Sep 2024
Director ceased
BHUSHAN SUDHIR BOPARDIKAR
Director ceased
Chhitiz Saraogi
17 May 2024
Director appointed
Chhitiz Saraogi (Director)
31 Mar 2024
Latest balance sheet
Filed with ROC
23 Jan 2024
Charge created
Others - 25.00 cr
28 Dec 2023
Charge created
Others - 50.00 cr
20 Jul 2023
Charge created
Yes Bank Limited - 50.00 cr
02 Jun 2023
Charge created
Others - 150.00 cr
18 Nov 2022
Securities allotted
486 Equity Shares - 6.70 cr raised
02 Nov 2022
Securities allotted
1257 Equity Shares - 17.32 cr raised
30 Sep 2022
Director ceased
NEERAJ SHARMA
10

Key Observations

Auto-generated from the data above
Revenue grew 38% over the last 2 financial year(s).
Net profit margin moved from 1.42 to 2.1x.
Debt-to-equity stands at 24% - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Operates a group structure with 1 subsidiary(ies) - assess on a consolidated basis.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a majority stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 7 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Hab Pharmaceuticals And Research Limited U99999MH1997PLC105340 Mumbai, Maharashtra, India
Zydus Hospira Oncology U24230GJ2005PTC046246 Village Matoda Tal Sanand, Gujarat, India
Surie Polex U74899DL2006PTC144325 New Delhi, Delhi, India
K.L.J. Polymers Private Limited U74999DL2020PTC360565 New Delhi, Delhi, India
Simalin Chemical Industries Private Limited U24299GJ1973PTC002211 Nandesari, Gujarat, India
Arene Lifesciences U24239TG2004PTC044199 Sangareddy, Telangana, India
Astron Zircon Private Limited U26933GJ2011PTC067384 Ahemedabad, Gujarat, India
The Asian Group U24290MH2010PTC199016 Mumbai, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Steriscience before audits and certifications: compliance score 80/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Steriscience: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 20/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 90/100, margin trends, ownership structure and peer set for Steriscience - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 70/100, distress signals and MSME payment-delay disclosures - know whether Steriscience pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Steriscience - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Steriscience an active company?

Steriscience has MCA status “Active” with a compliance score of 80/100 (Low Risk).

Is Steriscience financially healthy?

Steriscience has a Financial Health Score of 45/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Steriscience?

Its overall Trust Score is 70/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Steriscience?

The ultimate holding entity is Tenshi Pharmaceuticals Private Limited. 2 active director(s) are on record.

Does Steriscience have loans or charges against its assets?

4 open charge(s) are registered against its assets, and 3 earlier charge(s) stand satisfied.

Is Steriscience up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 80/100 (Low Risk).

Is it risky to lend to Steriscience?

Its Credit Risk Score is 20/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.